Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Medtronic
Chubb
Cerilliant
Novartis
Accenture
Daiichi Sankyo
McKesson
US Department of Justice

Generated: August 18, 2017

DrugPatentWatch Database Preview

PROPAFENONE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Propafenone Hydrochloride, and when can generic versions of Propafenone Hydrochloride launch?

Propafenone Hydrochloride is a drug marketed by Mylan Pharms Inc, Watson Labs, Vintage Pharms, Par Pharm, Orion Corp Orion, Ani Pharms Inc, Watson Labs Inc, Nesher Pharms, and Sun Pharm Inds. and is included in nine NDAs.

The generic ingredient in PROPAFENONE HYDROCHLORIDE is propafenone hydrochloride. There are eleven drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the propafenone hydrochloride profile page.

Summary for Tradename: PROPAFENONE HYDROCHLORIDE

Patents:0
Applicants:9
NDAs:9
Suppliers / Packagers: see list17
Bulk Api Vendors: see list37
Clinical Trials: see list2,270
Patent Applications: see list461
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROPAFENONE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: PROPAFENONE HYDROCHLORIDE

Drug ClassAntiarrhythmic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL203803-001Apr 29, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs Inc
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL202688-001Aug 24, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
TABLET;ORAL075998-001Nov 29, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Vintage Pharms
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
TABLET;ORAL075938-002Oct 17, 2002ABRXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
PROPAFENONE HYDROCHLORIDE
propafenone hydrochloride
TABLET;ORAL075203-001Oct 24, 2000ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Accenture
Deloitte
McKinsey
Moodys
US Department of Justice
Novartis
Cantor Fitzgerald
Dow
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot